» Articles » PMID: 28361904

IgE Binds Asymmetrically to Its B Cell Receptor CD23

Overview
Journal Sci Rep
Specialty Science
Date 2017 Apr 1
PMID 28361904
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The antibody IgE plays a central role in allergic disease mechanisms. Its effector functions are controlled through interactions between the Fc region and two principal cell surface receptors FcεRI and CD23. The interaction with FcεRI is primarily responsible for allergic sensitization and the inflammatory response, while IgE binding to CD23 is involved in the regulation of IgE synthesis and allergen transcytosis. Here we present the crystal structure of a CD23/IgE-Fc complex and conduct isothermal titration calorimetric binding studies. Two lectin-like "head" domains of CD23 bind to IgE-Fc with affinities that differ by more than an order of magnitude, but the crystal structure reveals only one head bound to one of the two identical heavy-chains in the asymmetrically bent IgE-Fc. These results highlight the subtle interplay between receptor binding sites in IgE-Fc and their affinities, the understanding of which may be exploited for therapeutic intervention in allergic disease.

Citing Articles

The evolution of flexibility and function in the Fc domains of IgM, IgY, and IgE.

Calvert R, Nyamboya R, Beavil A, Sutton B Front Immunol. 2024; 15:1389494.

PMID: 39445016 PMC: 11496790. DOI: 10.3389/fimmu.2024.1389494.


[Immunoglobulin E in nasal secretions].

Muhlmeier G, Tisch M HNO. 2024; 72(9):633-638.

PMID: 39031180 DOI: 10.1007/s00106-024-01499-8.


On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors.

Plattner K, Bachmann M, Vogel M Front Allergy. 2023; 4:1117611.

PMID: 37056355 PMC: 10089267. DOI: 10.3389/falgy.2023.1117611.


Generation and Characterization of Native and Sialic Acid-Deficient IgE.

McCraw A, Gardner R, Davies A, Spencer D, Grandits M, Wagner G Int J Mol Sci. 2022; 23(21).

PMID: 36362241 PMC: 9657026. DOI: 10.3390/ijms232113455.


IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms.

Kuo B, Li C, Chen J, Shiung Y, Chu C, Lee C J Clin Invest. 2022; 132(15).

PMID: 35912861 PMC: 9337824. DOI: 10.1172/JCI157765.


References
1.
Battye T, Kontogiannis L, Johnson O, Powell H, Leslie A . iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):271-81. PMC: 3069742. DOI: 10.1107/S0907444910048675. View

2.
Plomp R, Hensbergen P, Rombouts Y, Zauner G, Dragan I, Koeleman C . Site-specific N-glycosylation analysis of human immunoglobulin e. J Proteome Res. 2013; 13(2):536-46. DOI: 10.1021/pr400714w. View

3.
Fellmann M, Buschor P, Rothlisberger S, Zellweger F, Vogel M . High affinity targeting of CD23 inhibits IgE synthesis in human B cells. Immun Inflamm Dis. 2016; 3(4):339-49. PMC: 4693728. DOI: 10.1002/iid3.72. View

4.
Hibbert R, Teriete P, Grundy G, Beavil R, Reljic R, Holers V . The structure of human CD23 and its interactions with IgE and CD21. J Exp Med. 2005; 202(6):751-60. PMC: 2212946. DOI: 10.1084/jem.20050811. View

5.
Kelly A, Chen B, Woodward E, Conrad D . Production of a chimeric form of CD23 that is oligomeric and blocks IgE binding to the Fc epsilonRI. J Immunol. 1998; 161(12):6696-704. View